A Safety and Efficacy Study of Hospitalized Patients With Community-Acquired Pneumonia and Sepsis

Completed · Phase 2

Conditions studied: Pneumonia, Sepsis

In brief

The objective of this study is to demonstrate the safety and efficacy of IC14 in the treatment of hospitalized patients with community-acquired pneumonia and sepsis.

Key facts

Study ID

NCT00042588

Run by

ICOS Corporation

Starts

2002-05-01

Last updated by the study team

2005-06-24

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Current diagnosis of community-acquired pneumonia.
• Evidence of systemic inflammatory response to infection.

You may not qualify if…

• Atypical or viral pneumonia based on clinical or epidemiologic suspicion by the investigator.
• Presence of organ failure.

Where it is running

• ICOS Corporation — Bothell, Washington, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.